Implementing the National Cholesterol Education Program's update to the ATP III report.
The National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP III) report is widely used to establish risk-reduction target goals. The recent update to NCEP ATP III outlines additional treatment options for certain patient populations. The ambiguity inherent in providing optional therapeutic targets poses a challenge to disease management programs that establish standardized procedures requiring approval from physicians who refer patients to their programs. This report outlines a strategy for adapting the treatment option language into a viable standardized procedure.
Palmieri
James
J
Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, California, USA. Jpalmieri@chw.edu
D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards*; D014481:United States
D008078:Cholesterol, LDL